氯吡格雷治疗在体内外均能减少血小板血栓素A2的生成。 - Suppr

Suppr

超能文献

Reduction of platelet thromboxane A2 production ex vivo and in vivo by clopidogrel therapy.

作者信息

Armstrong P C J, Dhanji A-R A, Tucker A T, Mitchell J A, Warner T D

出版信息

J Thromb Haemost. 2010 Mar;8(3):613-5. doi: 10.1111/j.1538-7836.2009.03714.x. Epub 2009 Dec 3.

DOI:10.1111/j.1538-7836.2009.03714.x

PMID:19995405

Abstract

摘要

相似文献

Reduction of platelet thromboxane A2 production ex vivo and in vivo by clopidogrel therapy.

J Thromb Haemost. 2010 Mar;8(3):613-5. doi: 10.1111/j.1538-7836.2009.03714.x. Epub 2009 Dec 3.

Reversal of the anti-platelet effects of aspirin and clopidogrel.

J Thromb Haemost. 2012 Apr;10(4):521-8. doi: 10.1111/j.1538-7836.2012.04641.x.

Adrenoreceptors, platelet reactivity and clopidogrel resistance.

Thromb Haemost. 2008 Nov;100(5):729-30.

Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial.

Clin Ther. 2010 Feb;32(2):365-79. doi: 10.1016/j.clinthera.2010.02.015.

Assessment of platelet function in acute ischemic stroke patients previously treated with aspirin.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2794-2799. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.007. Epub 2014 Oct 16.

The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration.

Thromb Haemost. 2008 Feb;99(2):409-15. doi: 10.1160/TH07-09-0575.

Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease?

J Thromb Haemost. 2015 Jun;13(6):920-30. doi: 10.1111/jth.12909. Epub 2015 Apr 23.

Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.

J Cardiovasc Pharmacol. 2007 May;49(5):316-24. doi: 10.1097/FJC.0b013e31803e8772.

Clopidogrel response: head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting.

Arch Cardiovasc Dis. 2010 Jan;103(1):39-45. doi: 10.1016/j.acvd.2009.11.004. Epub 2010 Jan 25.

Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.

J Thromb Haemost. 2010 Jan;8(1):37-42. doi: 10.1111/j.1538-7836.2009.03644.x. Epub 2009 Oct 10.

引用本文的文献

Does one size really fit all? The case for personalized antiplatelet therapy in interventional cardiology.

Future Cardiol. 2024;20(9):499-515. doi: 10.1080/14796678.2024.2384217. Epub 2024 Aug 2.

Comparison of Short-Term DAPT and Long-Term DAPT on the Prognosis of PCI Patients: A Meta-Analysis of Randomized Controlled Trials.

Rev Cardiovasc Med. 2022 Sep 26;23(10):326. doi: 10.31083/j.rcm2310326. eCollection 2022 Oct.

The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention.

Korean Circ J. 2024 Apr;54(4):189-200. doi: 10.4070/kcj.2023.0268.

P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis.

Pharmaceuticals (Basel). 2023 Feb 3;16(2):232. doi: 10.3390/ph16020232.

Reduced-dose prasugrel monotherapy without aspirin after PCI with the SYNERGY stent in East Asian patients presenting with chronic coronary syndromes or non-ST-elevation acute coronary syndromes: rationale and design of the ASET Japan pilot study.

AsiaIntervention. 2023 Mar 15;9(1):39-48. doi: 10.4244/AIJ-D-22-00033. eCollection 2023 Mar.

Aspirin at 120: Retiring, recombining, or repurposing?

Res Pract Thromb Haemost. 2021 May 28;5(4):e12516. doi: 10.1002/rth2.12516. eCollection 2021 May.

P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: Is It Safe to Abandon Aspirin?

Acta Cardiol Sin. 2021 Jan;37(1):1-8. doi: 10.6515/ACS.202101_37(1).20200806A.

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial.

J Am Heart Assoc. 2020 Dec 15;9(24):e016495. doi: 10.1161/JAHA.120.016495. Epub 2020 Dec 11.

Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI.

Am J Cardiovasc Drugs. 2021 Mar;21(2):153-163. doi: 10.1007/s40256-020-00430-0.

Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.

JAMA. 2019 Jun 25;321(24):2428-2437. doi: 10.1001/jama.2019.8146.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验